Related by context. All words. (Click for frequent words.) 73 Edward Tenthoff 71 David Amsellem 69 analyst Cory Kasimov 68 Geoffrey Meacham 67 analyst Jim Reddoch 67 Geoff Meacham 66 analyst Liana Moussatos 66 analyst Jim Birchenough 66 Yaron Werber 65 Cory Kasimov 64 Matt Miksic 64 analyst Geoffrey Meacham 64 Alexandra Hauber 64 analyst Ken Trbovich 64 Geoff Porges 64 Moussatos 64 Eric Ende 63 Jason Kantor 63 Joshua Schimmer 63 Jim Birchenough 63 Jason Kolbert 63 Thom Gunderson 63 Bret Holley 63 analyst Mark Schoenebaum 63 Mark Schoenebaum 62 Andreas Theisen 62 Gbola Amusa 62 analyst Alexandra Hauber 62 analyst Amit Hazan 62 Sav Neophytou 62 analyst Jonathan Aschoff 62 Geoffrey Porges 62 Akhtar Samad 62 analyst Gbola Amusa 62 Olav Zilian 61 Joel Sendek 61 Monane 61 analyst Bruce Nudell 61 analyst Sapna Srivastava 61 Jami Rubin 61 Jeffrey Holford 61 Dr. Jim Birchenough 61 analyst Simos Simeonidis 60 analyst Randall Stanicky 60 Paul Cuddon 60 analyst Yaron Werber 60 Mark Monane 60 Liana Moussatos 60 analyst Glenn Novarro 60 analyst Lawrence Keusch 60 analyst Geoffrey Porges 60 Annabel Samimy 60 Raj Denhoy 60 analyst Glenn Reicin 60 Joseph Pantginis 59 analyst Mark Monane 59 Trevor Polischuk 59 Suresh Balaraman 59 reaffirmed Outperform rating 59 Dominic Valder 59 Carl Seiden 59 Jim Reddoch 59 analyst Raj Denhoy 59 analyst Hari Sambasivam 59 Phil Nalbone 59 Steven Harr 59 Ronny Gal 59 Jon Lecroy 58 Kevin Scotcher 58 analyst Phillip Nalbone 58 Glenn Reicin 58 analyst Annabel Samimy 58 Leerink Swan 58 Roopesh Patel 58 Navid Malik 58 analyst Bruce Cranna 57 Savvas Neophytou 57 Chris Shibutani 57 Pantginis 57 Michael Leuchten 57 Bruce Cranna 57 Tao Levy 57 Neely Tamminga 57 Kenji Masuzoe 57 Jeffrey Frelick 57 Robyn Karnauskas 57 analyst Navid Malik 57 analyst Andrew Goodsall 57 Liisa Bayko 56 Bert Hazlett 56 analyst Jami Rubin 56 Molowa 56 Ian Somaiya 56 Swiss brokerage Helvea 56 Schoenebaum 56 Larry Biegelsen 56 Holger Blum 56 WestLB Panmure 56 Bruce Nudell 56 Kin Ho 56 Scott Geels 56 analyst Joanne Wuensch 56 Geoff Ruddell 56 Aaron Reames 56 Finncap 56 Randall Stanicky 55 Kalpesh Kapadia 55 analyst Alex Gauna 55 Jonathan Aschoff 55 Navdeep Jaikaria 55 analyst Kristine Koerber 55 analyst Patrick Walravens 55 analyst George Grofik 55 Jason Gurda 55 analyst Alexander Peterc 55 George Grofik 55 Greg Geissman 55 reaffirmed Market Perform 55 JoAnne Feeney 55 Ananda Baruah 55 Kochnover 55 Jon LeCroy 55 analyst Sanjay Vidyarthi 55 David Molowa 55 analyst Shebly Seyrafi 55 Novo Nordisk NOVOb.CO 55 Isaac Ro 55 Tony Clapsis 55 analyst Maged Shenouda 55 Birgit Kulhoff 55 brokerage Helvea 55 Sven Borho partner 55 Simos Simeonidis 54 reaffirmed Neutral 54 Denhoy 54 Bernard Hanssens 54 Paul Mansky 54 analyst Junaid Husain 54 Damien Conover 54 Stacy Rasgon 54 Piper Jaffray PJC 54 Jesse Pichel 54 Anthony Gikas 54 Joe Pantginis 54 analyst Amit Bhalla 54 Tenthoff 54 Helvea 54 Gary Nachman 54 Jerry Doctrow 54 analyst Ajit Pai 54 Christopher Hogbin 54 Atsushi Seki 54 Dr. Yaron Werber 54 Morten Singleton 54 Claude Camire 54 Joanne Wuensch 54 reinitiated coverage 54 Martin Possienke 54 Katy Huberty 54 Jed Dorsheimer 54 Nick Spoliar 54 Trippitt 54 Nick Bertolotti 54 Medivation Inc 53 Helvea SA 53 Analyst Rebecca Arbogast 53 Glenn Novarro 53 Dhulsini de Zoysa 53 Vertex VRTX 53 Amir Rozwadowski 53 Gudme Raaschou 53 Andrew Kasoulis 53 Hamed Khorsand 53 Ulrich Huwald 53 Jonathan Dorsheimer 53 Neely JN Tamminga 53 Tad Piper 53 Claude Zehnder 53 Lawrence Biegelsen 53 Ken Cacciatore 53 analyst Rommel Dionisio 53 analyst Tore Svanberg 53 Gert Zonneveld analyst 53 Andrew Goodsall 53 Jeff Klinefelter 53 analyst Peter Misek 53 Julian Easthope 53 strategist Anais Faraj 53 analyst Jeffrey Zekauskas 53 Tony Shiret analyst 53 Cantor Fitzgerald reiterates 53 Neurosearch 53 Christian Koefoed Nielsen 53 Andrew Vaino 53 analyst Fabrizio Croce 53 Randal Konik 52 Yasuhiro Nakazawa 52 William Plovanic 52 economist Ryo Hino 52 John DiFucci 52 Evolution Beeson Gregory 52 Jean Philippe Bertschy 52 analyst Mahesh Sanganeria 52 Rajesh Ghai 52 analyst Walter Piecyk 52 analyst Seamus Fernandez 52 analyst Romit Shah 52 BernsteinResearch 52 Quynh Pham 52 Reiterates Hold 52 Mark Ebbinghaus 52 Analyst Cody Acree 52 Hans Joachim Lohrisch 52 Simeonidis 52 Joshua Raskin 52 Shaojing Tong 52 Cormac Leech 52 analyst Jeff Fidacaro 52 AstraZeneca AZN.ISE 52 Sara Elford 52 analyst Nigel Dally 52 Analyst Gene Munster 52 Cannacord Genuity 52 Keay Nakae 52 Aderis 52 analyst Antony Broadbent 52 Suraj Kalia 52 analyst Jesse Pichel 52 analyst Mario Mendonca 52 Barrie Cornes analyst 52 Healthcare Conf 52 Ingrid Ebeling 52 Mike Krensavage 52 Dr. Joshua Schimmer 52 analyst Chad Friess 52 Karl Heinz Scheunemann 52 analyst Emme Kozloff 52 Novartis Gilenia 52 analyst Robert Cihra 52 Julian Heslop 52 analyst Shinya Yamada 51 analyst Ghansham Panjabi 51 Gerry Hennigan 51 Wolfgang Renner 51 analyst Ambrish Srivastava 51 Arjan van Veen 51 analyst Harm Meijer 51 analyst Michael Exstein 51 Brent Thill 51 analyst Jaap Meijer 51 Resumes Coverage 51 Eric Coldwell 51 Antoine Leurent 51 Groschke 51 Karl Heinz Koch 51 analyst Julian Easthope 51 Betsy Van Hees 51 analyst Tim Klasell 51 Douglas Anmuth 51 Helvea AG 51 Elan Tysabri 51 Analysts Initiate Coverage 51 Darren Lehrich 51 analyst Gurinder Kalra 51 Jeremy Sigee 51 analyst Laurent Horrut 51 Cannacord Adams 51 analyst Tony Shiret 51 analyst Ross Muken 51 analyst Jeffrey Klinefelter 51 analyst Mark Lipacis 51 Panagiotis Spiliopoulos 51 Daniel Meron 51 Sven Borho 51 Maintains Neutral 51 Kristine Koerber 51 James Manuso 51 Ton van Ooijen 51 Richard Menzies Gow 51 Sterling Auty 51 Leerink 51 Richard Slape 51 Amylin Eli Lilly 51 analyst Frank Mitsch 51 Erik Bloomquist 51 Girish Tyagi 51 Saftlas 51 Lars Ekman 51 analyst Mitch Kummetz 51 Carla Antunes da Silva 51 analyst Youssef Ziai 51 Vishal Shreedhar 51 Jonathan Imlah 51 Ranjit Kapadia 51 CE Unterberg 51 Brian Piccioni 51 analyst Gert Zonneveld 51 analyst Elemer Piros 51 Liam Igoe 51 Dolat Capital Market 51 Dolmen Securities 50 Pat Walravens 50 Matthew Emmens 50 Lawrence Keusch 50 analyst Omotayo Okusanya 50 Patrick Walravens 50 analyst Rebecca Runkle 50 Dara Mohsenian 50 Seattle Genetics SGEN 50 Gets Downgraded 50 analyst Hideyuki Maekawa 50 Forest Labs FRX 50 Daniel Berenbaum 50 Paul Averback 50 Xenoport Inc. 50 analyst Larry Biegelsen 50 analyst Ehud Gelblum 50 Fabrizio Croce 50 Claudia Shank Hueston 50 Ricky Goldwasser 50 Piper Jaffray reiterate 50 told Outsourcing Pharma.com 50 Timothy Thein 50 analyst Greg Feehely 50 Matthew McEachran analyst 50 analyst Jeffrey Kvaal 50 Reiterate Outperform rating 50 NASDAQ ONXX 50 Joanna Makris 50 Maintains Buy 50 Piper Jaffray downgraded 50 Andreas Willi 50 Tore Svanberg 50 Jay Vleeschhouwer 50 Ken Trbovich 50 Clozel 50 Rating Maintained 50 analyst Reto Huenerwadel 50 Kathryn Huberty 50 analyst Hamed Khorsand 50 ThinkPanmure 50 Robin Chhabra 50 Helene Wolk 50 Vijay Rakesh 50 Tony Shiret 50 analyst Shinichi Ina 50 Reiterates Neutral Rating 50 Biomarin 50 Jean Pierre Lehner 50 Pablo Zuanic 50 economist Masaaki Kanno 50 Biogen IDEC 50 Manoj Garg 50 Curagen 50 Nasdaq GPRO announced 50 Luuk van Beek 50 Reiterates Outperform 50 Steve Massocca 50 Sanjay Vidyarthi 50 Todd Bault 50 Ton Gietman 50 Marco Strittmatter 50 Analyst Safa Rashtchy 50 Nasdaq IDIX 50 Mabthera 50 analyst Thilo Wrede 50 analyst Victor Bareno 50 strategist Teun Draaisma 50 Marc Cluzel 50 Assumes Coverage 50 told BioWorld Today 50 Gilead GILD 50 Exane BNP 50 PiperJaffray analyst 50 Yoshihiko Hatanaka 50 Srini Pajjuri 49 Sara Michelmore 49 ABX EGF 49 Hugh Guy Lorriman 49 Gary Giblen 49 Bapty 49 Phillip Nalbone 49 Oliver Gilvarry 49 analyst Randal Konik 49 macitentan 49 Mikir Shah 49 Nikos Theodosopoulos 49 Funtleyder 49 Matt Emmens 49 Christopher Danely 49 analyst Shaul Eyal 49 spokeswoman Caroline Pecquet 49 Elmar Schnee 49 Tim Klasell 49 Piper Jaffray reiterates 49 Petercam analyst 49 Rachael Waring 49 Andrew Gollan 49 John Calcagnini 49 Kenneth Zaslow 49 Orville Kolterman 49 brokerage Numis 49 Redburn Partners 49 analyst Ananda Baruah 49 analyst Silke Stegemann 49 Daniel Fannon 49 Matthew Kather 49 analyst Julio Quinteros 49 Jeffrey Bencik 49 Reiterate Buy rating 49 analyst Robert Campagnino 49 ThinkEquity upgraded 49 NASDAQ ACOR 49 Greg Feehely 49 Ambrish Srivastava 49 Helvea analyst Olav Zilian 49 Jeffrey Klinefelter 49 analyst Uche Orji 49 analyst Shinichi Ichikawa 49 analyst Kian Abouhossein 49 analyst Louis Miscioscia 49 Makoto Yamashita strategist 49 Prashant Nair 49 Roche Mircera 49 Exanta 49 Piper Jaffrey 49 Amgen Prolia 49 Biogen multiple sclerosis 49 Kulbinder Garcha 49 Cailey Barker 49 analyst Tim Savageaux 49 Amylin AMLN 49 Kemp Dolliver 49 strategist Mike Lenhoff 49 Geraud Charpin 49 analyst Srini Pajjuri 49 Louis Miscioscia 49 analyst Konrad Becker 49 Piper Jaffray nyse PJC 49 Reik Read 49 analyst Angelos Anastasiou 49 Sanganeria 49 Satoru Ogasawara strategist 49 analyst Irene Nattel 49 RBC Capital Mkts Reiterate 49 analyst Dorothy Lakner 49 Vontobel analyst 49 Maintains Hold 49 Kevin Ellich 49 Bryan Garnier 49 analyst Gregory Badishkanian 49 Barclays Capital Reiterate Overweight 49 Mark Lipacis 49 Andrew Nussey 48 Nigel Parson 48 Al Kaschalk 48 Brion Tanous 48 Dorothy Lakner 48 analyst Christa Quarles 48 Natixis Bleichroeder analyst 48 Sandra McCullagh 48 Leerink analyst 48 analyst Frederick Searby 48 Thomas Cholnoky 48 Neutral Weight 48 ThinkEquity downgraded 48 brokerage Cheuvreux 48 analyst Amit Daryanani 48 Phil Skolnick 48 Merck boceprevir 48 analyst Maynard Um 48 Wendell Zerb 48 analyst Robyn Karnauskas 48 analyst Dougie Youngson 48 Nathan Schneiderman 48 economist Rainer Guntermann 48 Roland Haefeli 48 economist Laurent Bilke 48 Mislav Matejka 48 Nick Batram 48 Vontobel analyst Andrew 48 Matthew Heimermann 48 Steven Alexopoulos 48 analyst Raghu Hariharan 48 Maher Yaghi 48 Intermune 48 CorporateCommunications +#-#-#-# 48 Piper Jaffrey analyst 48 Tobias Levkovich 48 analyst Albert Savastano 48 Manus Costello 48 analyst Maarten Altena 48 strategist Satoru Ogasawara 48 Farooq Hanif 48 Robin Bienenstock 48 Barry Labinger 48 Mahesh Sanganeria 48 Maintains Overweight 48 strategist Graham Secker 48 Laboratories Rahway NJ 48 Analyst Toni Sacconaghi 48 Analyst Ben Reitzes 48 analyst Elizabeth Osur 48 analyst Mehdi Hosseini 48 Sepracor SEPR 48 Uche Orji 48 Maintains Hold Rating 48 analyst Katherine Styponias 48 Analysts Downgrade 48 Delafield Hambrecht 48 Krensavage 48 analyst Cusson Leung 48 Reiterates Hold Rating 48 Krystexxa 48 Xenoport 48 Bob Drbul 48 economist Joachim Fels 48 economist Stephane Deo 48 analyst Jay Defibaugh 48 Landsbanki Kepler analyst 48 Eli Kammerman 48 George Scangos 48 analyst Dara Mohsenian 48 Broker Roundup 48 Amylin Pharmaceuticals Nasdaq AMLN 48 Bhavin Shah 48 Karen Boodram 48 Suneet Kamath 48 Koya Tabata analyst 48 Erkki Vesola 48 Charlie Di Bona 48 Seymour Pierce reiterates 48 Eyetech Pharmaceuticals 48 Brian Bapty 48 Clive Forestier Walker 48 Ana Gupte 48 Katharine Wynne 48 Brett Manderfeld 48 Elliott Sigal 48 Daniele Antonucci 48 Dr. Gail Cawkwell 48 Anthony Bucalo 48 Orbimed 48 Youssef Ziai 48 Michael Shillaker 48 Kaufman Bros reiterate 48 Michael Krensavage 48 analyst Koya Tabata 48 Gerald Khoo 48 Julien Roch 48 Hollings Renton 48 April Scee 48 Silversteyn 48 Maintains Neutral Rating 48 analyst Charles Boorady 47 BoA Merrill Lynch 47 Garo Toomajanian 47 analyst Pablo Zuanic 47 Andy Kaplowitz 47 Mihael Polymeropoulos 47 David Jeary 47 Stefaan Genoe 47 D mab 47 Armando Anido 47 Joshua Shanker 47 Reiterates Buy Rating 47 Louise Makin 47 Douglas Harned 47 Reiterates Buy rating 47 analyst Sterling Auty 47 Reiterates Sell 47 BoA ML 47 Roman Cizdyn 47 Vertex Pharmaceuticals NASDAQ VRTX 47 AMAG Pharma 47 Anders Trapp 47 analyst Hisashi Moriyama 47 Willem Sels 47 Simon Lowth 47 Analyst Joseph Greff 47 Shiv Kapoor 47 Nicola Mallard 47 analyst Steven Wieczynski 47 Arnaud Langlois 47 Sid Parakh analyst 47 Patrik Schwendimann 47 analyst Vivek Arya 47 Charles Boorady 47 Bayer BAY.ETR 47 Ehud Gelblum 47 strategist Makoto Yamashita 47 JMP Securities downgrade 47 Mark Bacurin 47 Ahmar Zaman 47 economist Elga Bartsch 47 Analyst Richard Withagen 47 analyst Robert Drbul 47 Justin Hott 47 Alexandra Oldroyd 47 Dirk Hoffmann Becking 47 Nollenberger Capital 47 analyst Allan Mishan 47 Olivia Ker 47 WR Hambrecht reiterate 47 Affymax AFFY 47 Seamus Fernandez 47 Meredith Adler 47 Suji De Silva 47 Orbimed Advisors LLC 47 Inc CYBX 47 Sam Buttrick 47 Jesse Tortora 47 Nicholas Aberle 47 analyst Morten Singleton 47 David Hochstim 47 analyst Dinesh Moorjani 47 Johan Eliason 47 marketperform 47 analyst Sven Kreitmair 47 IG HCR ;) CO 47 Inc. NASDAQ ITMN 47 Bank Vontobel analyst 47 NASDAQ ADLR 47 Auxilium Pharma 47 SoundView Technology 47 Genentech Herceptin 47 Matthew DiFrisco 47 Lars Kjellberg 47 Joseph Amaturo 47 Optimer Pharmaceuticals 47 Kian Abouhossein 47 Jay Gelb 47 analyst William Pecoriello 47 Idenix Pharmaceuticals 47 Reiterates Buy 47 Nigel Dally 47 Anton Wahlman 47 Lauren Cooks Levitan 47 Bernd Seizinger 47 Alastair Benbow 47 Jeff Wlodarczak 47 equalweight rating 47 Amgen denosumab 47 Moncef Slaoui 47 Patricia Oey 47 Pierre Ferragu 47 Bank Vontobel 47 Jeff Kvaal 47 Darren Aftahi 47 James Janesky 47 BioMedTracker 47 Carl Pelzel 47 Inc CEPH 47 Shari Schwartzman Eberts 47 Nasdaq IPXL 47 analyst Maher Yaghi 47 Joe Osha 47 Nasdaq BMRN 47 Pascal Soriot 47 Evgeny Solovyov 47 analyst Ajay Jain 47 Analyst Sid Parakh 47 Satya Kumar 47 Rob Cihra 47 Irene Himona 47 Alnylam Nasdaq ALNY 47 Analyst Dick Bove 47 Equinet analyst 47 Lazard Capital 47 Peer Schatz 47 W. Ruttenbur 47 Timothy Arcuri 47 analyst Alvin Kwock 47 Theo Kitz 47 Ed Groshans 47 Satya Chillara 47 Michael Bruynesteyn 47 analyst Michael Masdea 47 NASDAQ ANDS 47 GILD GILD 47 JMP Securities downgraded 47 analyst Joshua Shanker 47 analyst Vishal Shreedhar 47 Broker Panmure Gordon 47 analyst Jesse Tortora 47 Jochen Rothenbacher 47 Piper Jaffray 47 analyst Alexia Quadrani 47 Shuji Shirota economist 47 Moszkowski wrote 47 GlaxoSmithKline PLC GSK.LN 47 Benlysta belimumab 47 Anadys Pharmaceuticals 47 Polymeropoulos 47 spokesman Jose Juves 47 Inc HGSI.O 47 Andrew Kligerman 47 analyst Yuji Fujimori 47 Singer Capital Markets 47 TSRX 47 analyst Stacey Widlitz 47 analyst Brent Thill 47 NovoNordisk 47 Ariel Sokol 47 Drew Brosseau 47 Jorge Beristain 47 Jesper Brandgaard 47 analyst Jeffrey Holford 46 analyst Vijay Jayant 46 analyst Ashwin Shirvaikar 46 Chris Umiastowski 46 Ross Muken 46 Safi Bahcall Ph.D. 46 analyst Charles Kernot 46 Craig Siegenthaler 46 RW Baird analyst 46 Inc. NASDAQ EVVV 46 Craig Woker 46 CAI Cheuvreux 46 Vivek Arya 46 Azad Zangana 46 Elisabeth Afseth 46 Rommel Dionisio 46 Steven Burakoff 46 Julian Callow economist 46 NV1FGF 46 Philip Dorgan 46 Anais Faraj strategist 46 economist Ted Wieseman 46 Trevor Mundel 46 Tejinder Randhawa 46 PiperJaffray 46 analyst Katy Huberty 46 Charles Grom 46 analyst Brad Reback 46 Landsbanki reiterating 46 Noah Beerman 46 PJ Juvekar 46 Dr. LaMattina 46 Versant Partners analyst 46 Simon Moroney 46 analyst Edwin Mok 46 Shire PLC SHP.LN 46 analyst Bruce Harting 46 David Hallden 46 Maintains Outperform 46 analyst Thorsten Wenzel 46 analyst Sasa Zorovic 46 Mark Edelstone 46 Creditsights 46 Ken Zerbe 46 Onyx Pharma 46 analyst Anthony Chukumba 46 generic Lovenox 46 Oncogenex 46 analyst Edmo Chagas 46 Isis Pharma 46 Joel Fishbein 46 ImmunoGen IMGN 46 Richard Treagus 46 Melanie Flouquet 46 Martin Deboo 46 Bhavtosh Vajpayee 46 analyst Randy Binner 46 analyst Michael Bruynesteyn 46 Mark Schappel 46 NASDAQ ALXN 46 Harm Meijer 46 Sector Outperform 46 reinitiates coverage 46 John Segrich 46 analyst Mark Edelstone 46 economist Chetan Ahya 46 analyst Constance Maneaty 46 analyst Amir Rozwadowski 46 Suresh Mahadevan 46 Doliveux 46 Jeremy Sussman 46 Kaumil Gajrawala 46 Christian Weiz 46 Vioxx Zocor 46 Pete Paradossi 46 BioMarin Pharma 46 economist Sonal Varma 46 Ariad Pharmaceuticals 46 Natexis Bleichroeder analyst 46 Switzerland Serono SA 46 Landsbanki Kepler 46 Stanicky 46 Plachetka 46 economist George Tharenou 46 Michael Blogg 46 analyst Rob Rutschow 46 midstage clinical 46 Andrew Garthwaite 46 Tristan Gerra 46 analyst Simona Jankowski 46 Sumit Malhotra 46 analyst Dean Gianoukos 46 FTN Equity Capital 46 McCamant 46 Duane Grubert 46 Bonte Friedheim 46 WR Hambrecht analyst 46 Takehiro Sato economist 46 analyst Masahiro Ono 46 Yang Sy Jian 46 Ziopharm 46 United Therapeutics UTHR 46 Doug Anmuth 46 analyst Margaret Mager 46 analyst Jeffrey Fidacaro 46 Merrion Capital 46 Actelion Pharmaceuticals Ltd. 46 Kepler Equities analyst 46 Roger Perlmutter Amgen 46 Birchenough 46 Morgan Stanely 46 Orbimed Advisors 46 ONXX 46 analyst Kemp Dolliver 46 NASDAQ PCYC 46 Dresdner Kleinwort Wasserstein DKW 46 Charles DiBona 46 spokeswoman Lenore Gelb 46 Eithne O'Leary 46 Capital Markets Espana 46 ANALYST TAKE Goldman Sachs 46 analyst Satya Chillara 46 Francesco Garzarelli 46 Brock Salier 46 Broadpoint.AmTech analyst 46 Bruce Kuhlik 46 analyst Onno Rutten 46 economist Dana Saporta 46 strategist Adrian Mowat 46 Sanjiv Wadhwani 46 economist Hiromichi Shirakawa 46 analyst Joseph Altobello 46 Peter Rozenberg 46 Victoria Kusiak 46 James Covello 46 Scot Ciccarelli 46 Kirk Materne 46 Schwab SoundView 46 Alastair Riddell 46 Neibor 46 ANALYST TAKE Lehman Brothers 46 nasdaq HGSI news 46 Bo Piela 46 Rajiv Gulati 46 Tushar Poddar economist 46 Nicholas Landekic 46 Acrux Limited 46 Donald Fandetti 46 Anindya Mohinta 46 Adventrx 46 analyst Safa Rashtchy 46 Laurence Mutkin 46 Lilly Amylin 46 Corp Plc ELN.I 45 analyst Christopher Danely 45 analyst Deane Dray 45 Daljeet Kohli head 45 Robert Cihra 45 Matthew Borsch 45 strategist Abhijit Chakrabortti 45 analyst Peter Lisnic 45 Raymund Breu 45 analyst Charles Neivert 45 Huw van Steenis 45 Marketperform 45 Vik Grover 45 Recentin 45 Kevin Buchi 45 Camvia 45 Michael Nawrath 45 Matt Nemer 45 analyst Ben Reitzes 45 Kepler Equities 45 Mike Trippitt analyst 45 Ciaran Callaghan 45 Ron Bentsur 45 Viwat strategist 45 Robert Koort 45 Matthew Fassler 45 Lowers Estimates 45 Eliseo Salinas 45 Dificid 45 Atherogenics 45 strategist Tony Crescenzi 45 Prabhat Awasthi 45 Pfizer inhaled insulin 45 Porges 45 Brock Vandervliet 45 Janardan Menon 45 analyst Benjamin Reitzes 45 Equinet 45 analyst Jason Napodano 45 Ian de Verteuil 45 Dr. Emilio Emini 45 Ivailo Vesselinov 45 Curt Woodworth 45 analyst Tony Wible 45 Insmed Incorporated NASDAQ INSM 45 Salmedix 45 Remi Barbier 45 David Begleiter 45 Scott Mushkin 45 Suntrust Robinson Humphrey 45 Ivan Lathouders 45 Rick Sherlund 45 Clay Siegall 45 analyst Lori Appelbaum 45 economist Sunil Kapadia 45 Stanley Crooke 45 Rating Reiterated 45 Kimberly Greenberger 45 Glen Yeung 45 Nilesh Jasani 45 Eric Siemers 45 Jon Arfstrom 45 spokeswoman Mariann Caprino 45 Grofik 45 Ryland Presentation 45 Westhall Capital 45 Constantine Davides 45 analyst Edward Yruma 45 Matthew Sheerin 45 strategist Brian Belski 45 BWS Financial 45 AGā 45 Finola Burke 45 Mark Astrachan 45 Tesofensine 45 Drakeman 45 analyst Erik Suppiger 45 Nik Modi 45 Paul Lejuez 45 Merrion Stockbrokers 45 Bank Degroof analyst 45 Nick Selvaratnam 45 Vance Edelson 45 Pedro Lichtinger 45 analyst Jason Gurda 45 Chris Danely 45 David Turkaly 45 Ixis Securities 45 Krishna Shankar 45 Destin Tompkins 45 analyst Yoshiharu Izumi 45 Tien tsin Huang 45 analyst Kimberly Greenberger 45 Alexia Quadrani 45 Aurel Leven 45 Christopher Horvers 45 Christopher LaFemina 45 Elga Bartsch economist 45 Benjamin Mogil 45 Preos 45 Sol Barer 45 Kash Rangan 45 Kyoya Okazawa 45 analyst Noriyuki Matsushima 45 Sector Outperformer 45 analyst Curtis Shauger 45 Gilead Sciences nasdaq GILD 45 Underweight rating 45 NASDAQ TWPG 45 Piper Jaffray analyst 45 Bernhard Scheuble 45 Walter Piecyk 45 Jonathan Groocock 45 Wells Fargo Initiates Coverage 45 analyst Jonathan Schildkraut 45 analyst Inder Singh 45 analyst Chandan Sarkar 45 QLT CN 45 Grasher 45 Broker Investec 45 Hoji Alimi founder 45 Brad Reback 45 Danske Equities 45 Punk Ziegel 45 analyst Tristan Gerra 45 Fernand de Boer 45 Andrew Obin 45 Catalyst Biosciences 45 Michael Rehaut 45 Brigantine Advisors analyst 45 Robert Drbul 45 analyst Wim Hoste 45 Nasdaq MOGN 45 Maintains Sell 45 Maraganore 45 analyst Darin Arita 45 Igor Gonda 45 Medical STJ 45 MyVax personalized immunotherapy